These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33277736)

  • 1. A bundled phosphate control intervention (4Ds) for adults with end-stage kidney disease receiving haemodialysis: A cluster randomized controlled trial.
    Milazi M; Douglas C; Bonner A
    J Adv Nurs; 2021 Mar; 77(3):1345-1356. PubMed ID: 33277736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bundled phosphate control intervention (4Ds) for adults with end-stage kidney disease receiving haemodialysis: A cluster randomized controlled trial protocol.
    Milazi M; Douglas C; Bonner A
    J Adv Nurs; 2018 Oct; 74(10):2431-2441. PubMed ID: 29943430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis Self-management Intervention Randomized Trial (HED-SMART): A Practical Low-Intensity Intervention to Improve Adherence and Clinical Markers in Patients Receiving Hemodialysis.
    Griva K; Nandakumar M; Ng JH; Lam KFY; McBain H; Newman SP
    Am J Kidney Dis; 2018 Mar; 71(3):371-381. PubMed ID: 29198641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patients.
    Wileman V; Farrington K; Wellsted D; Almond M; Davenport A; Chilcot J
    Br J Health Psychol; 2015 Sep; 20(3):563-78. PubMed ID: 25209368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.
    Chen N; Wu X; Ding X; Mei C; Fu P; Jiang G; Li X; Chen J; Liu B; La Y; Hou F; Ni Z; Fu J; Xing C; Yu X; Huang C; Zuo L; Wang L; Hunter J; Dillon M; Plone M; Neylan J
    Nephrol Dial Transplant; 2014 Jan; 29(1):152-60. PubMed ID: 24151017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of nurse-led education on haemodialysis patients' phosphate binder medication adherence.
    Sandlin K; Bennett PN; Ockerby C; Corradini AM
    J Ren Care; 2013 Mar; 39(1):12-8. PubMed ID: 23432740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of community pharmacist-led intensive education on the control of serum phosphate levels in haemodialysis patients.
    Suzuki H; Uchida S; Kashiwagura Y; Tanaka S; Yamauchi K; Kageyama S; Namiki N
    Int J Clin Pharm; 2021 Feb; 43(1):220-228. PubMed ID: 32955654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis.
    Edmonston DL; Isakova T; Dember LM; Brunelli S; Young A; Brosch R; Beddhu S; Chakraborty H; Wolf M
    Am J Kidney Dis; 2021 Jun; 77(6):920-930.e1. PubMed ID: 33279558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN; Lewis JB; Dwyer JP; Greene T; Middleton J; Sika M; Umanath K; Abraham JD; Arfeen SS; Bowline IG; Chernin G; Fadem SZ; Goral S; Koury M; Sinsakul MV; Weiner DE;
    Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of educational interventions with dialysis patient].
    Parmier M; Gourieux B; Krummel T; Bazin-Kara D; Dory A; Hannedouche T
    Nephrol Ther; 2016 Dec; 12(7):516-524. PubMed ID: 27776970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients.
    Morey B; Walker R; Davenport A
    Nephron Clin Pract; 2008; 109(3):c173-80. PubMed ID: 18663331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.
    Chan MW; Cheah HM; Mohd Padzil MB
    Int J Clin Pharm; 2019 Oct; 41(5):1282-1289. PubMed ID: 31302884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to improve dietary, fluid, dialysis or medication adherence in patients with end stage kidney disease on dialysis: A systematic review and meta-analysis of randomized intervention trials.
    Murali KM; Mullan J; Roodenrys S; Hassan HC; Lambert K; Lonergan M
    PLoS One; 2019; 14(1):e0211479. PubMed ID: 30695068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventional study to improve adherence to phosphate binder treatment in dialysis patients.
    Hjemås BJ; Bøvre K; Mathiesen L; Lindstrøm JC; Bjerknes K
    BMC Nephrol; 2019 May; 20(1):178. PubMed ID: 31101020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a nurse-led intensive educational programme on chronic kidney failure patients with hyperphosphataemia: randomised controlled trial.
    Shi YX; Fan XY; Han HJ; Wu QX; Di HJ; Hou YH; Zhao Y
    J Clin Nurs; 2013 Apr; 22(7-8):1189-97. PubMed ID: 23480506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
    Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ
    Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
    Cervelli MJ; Shaman A; Meade A; Carroll R; McDonald SP
    Nephrology (Carlton); 2012 Jul; 17(5):458-65. PubMed ID: 22471559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis.
    Saif I; Halim A; Altaf A; Saif M; Khalid M; Ahmad D; Imran H
    J Ayub Med Coll Abbottabad; 2007; 19(4):26-8. PubMed ID: 18693591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing serum phosphate in haemodialysis patients: time for an innovative approach?
    Collinson A; McMullan M; Tse WY; Sadler H
    Eur J Clin Nutr; 2014 Mar; 68(3):392-6. PubMed ID: 24424075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit.
    Davenport A; Gardner C; Delaney M;
    Nephrol Dial Transplant; 2010 Mar; 25(3):897-901. PubMed ID: 19875379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.